Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Deep Common Bile Duct Cannulation Time During Endoscopic Retrograde Cholangiopancreatography Be Shortened by Dexamethasone

NCT05945797 is registered in ClinicalTrials.gov with Gujranwala medical college District Headquarters Hospital, Gujranwala as lead sponsor.

NCT NCT05945797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05945797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Deep Common Bile Duct Cannulation Time During Endoscopic Retrograde Cholangiopancreatography Be Shortened by Dexamethasone
Lead sponsor
Gujranwala medical college District Headquarters Hospital, Gujranwala
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2023
Completion date
May 16, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common bile duct calculi, common bile duct dilatation, common bile duct diseases, common bile duct neoplasms, common bile duct stricture